These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 6978580

  • 1. [Immunological characteristics of malignant skin lymphomas].
    Shaposhnikov OK, Rodionov AN.
    Vestn Dermatol Venerol; 1982 Mar; (3):4-11. PubMed ID: 6978580
    [No Abstract] [Full Text] [Related]

  • 2. [Immunocytological study of cutaneous malignant lymphomas. Classification (author's transl)].
    Souteyrand P, Thivolet J, Alario A, Schmitt D, Perrot H.
    Dermatologica; 1978 Mar; 157(5):268-81. PubMed ID: 150348
    [Abstract] [Full Text] [Related]

  • 3. [Immunological characterization of malignant epidermotropic lymphoma cells in cutaneous infiltrates (author's transl)].
    Thivolet J, Souteyrand P, Alario A, Schmitt D, Perrot H.
    Dermatologica; 1978 Mar; 157(6):357-64. PubMed ID: 363474
    [Abstract] [Full Text] [Related]

  • 4. [Functional status of lymphocytes from the lymph nodes of patients with malignant lymphomas of the skin].
    Shaposhnikov OK, Genter EI, Rodionov AN.
    Vestn Dermatol Venerol; 1982 Aug; (8):4-7. PubMed ID: 7148128
    [No Abstract] [Full Text] [Related]

  • 5. Recent advances in the cutaneous T cell lymphomas.
    Edelson RL.
    Bull Cancer; 1977 Aug; 64(2):209-24. PubMed ID: 303131
    [Abstract] [Full Text] [Related]

  • 6. [Sézary syndrome. Clinical, immunological and proliferative kinetics].
    Marosi L, Hofer F, Schwarzmeier J, Konrad K, Knapp W, Radaskiewicz T.
    Acta Med Austriaca; 1979 Aug; 6(5):237-40. PubMed ID: 318012
    [Abstract] [Full Text] [Related]

  • 7. Clinical and hematological heterogeneity of T-cell derived lymphoproliferative diseases.
    Brouet JC, Flandrin G.
    Bull Cancer; 1977 Aug; 64(2):267-74. PubMed ID: 143976
    [Abstract] [Full Text] [Related]

  • 8. Patterns of cutaneous lymphomas. Histological, enzyme cytochemical, and immunological typing of lymphoreticular proliferations in the skin.
    Burg G, Braun-Falco O, Hoffmann-Fezer G, Rodt H, Schmoeckel C.
    Dermatologica; 1978 Aug; 157(5):282-91. PubMed ID: 150349
    [Abstract] [Full Text] [Related]

  • 9. [Immunologic phenotyping of cutaneous lymphomas].
    Kaudewitz P, Burg G, Smolle J, Braun-Falco O.
    Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
    Serov AA, Kadagidze ZG.
    Vopr Onkol; 1983 Dec; 29(12):18-20. PubMed ID: 6607569
    [Abstract] [Full Text] [Related]

  • 11. [The immune status of patients with lymphoproliferative diseases of the skin and Kaposi's sarcoma].
    Faradzhev ZG, Derevnina NA, Ivshina AV.
    Vestn Dermatol Venerol; 1990 Dec; (1):16-20. PubMed ID: 2327165
    [Abstract] [Full Text] [Related]

  • 12. [IgE and cellular immunity in cutaneous lymphomas (author's transl)].
    Guilhou JJ, Clot J, Robinet-Lévy M, Meynadier J.
    Ann Dermatol Venereol; 1977 Dec; 104(8-9):533-7. PubMed ID: 303883
    [Abstract] [Full Text] [Related]

  • 13. [T-lymphocytes in the peripheral blood and lymph nodes in lymphatic system diseases].
    Michlmayr G, Huber C, Fink U, Falkensammer M, Huber H.
    Schweiz Med Wochenschr; 1974 Jun 08; 104(23):815-20. PubMed ID: 4546217
    [No Abstract] [Full Text] [Related]

  • 14. [In situ - demonstration of helper-T-lymphocytes in cutaneous malignant lymphomas by diaminopeptidase IV (DAP IV)].
    Sterry W, Steigleder GK, Goos M, Meisterernst E.
    Z Hautkr; 1982 Apr 15; 57(8):567-76. PubMed ID: 6124066
    [Abstract] [Full Text] [Related]

  • 15. [The immunocompetent structures of the skin and their role in the development of primary skin lymphomas].
    Vavilov AM, Lezvinskaia EM.
    Arkh Patol; 1996 Apr 15; 58(6):7-12. PubMed ID: 9139599
    [Abstract] [Full Text] [Related]

  • 16. [Immunological markers in the differential diagnosis of systemic lymphatic diseases (author's transl)].
    Huber CH, Michlmayr G, Huber H.
    Dtsch Med Wochenschr; 1974 Nov 08; 99(45):2262-8. PubMed ID: 4548666
    [No Abstract] [Full Text] [Related]

  • 17. T and B cells and cell-mediated immunity in mycosis fungoides.
    Nordqvist BC, Kinney JP.
    Cancer; 1976 Feb 08; 37(2):714-8. PubMed ID: 130203
    [Abstract] [Full Text] [Related]

  • 18. [Studies of cutaneous malignant lymphoma--especially about T gamma cell (author's transl)].
    Shimokawa Y.
    Nihon Hifuka Gakkai Zasshi; 1982 Feb 08; 92(2):149-55. PubMed ID: 6979648
    [No Abstract] [Full Text] [Related]

  • 19. [Immunological aspects of malignant lymphomas].
    Hancock BW, Richmond J.
    Recenti Prog Med; 1978 Feb 08; 64(2):217-29. PubMed ID: 347546
    [No Abstract] [Full Text] [Related]

  • 20. Expression of monoclonal antibody HML-1-defined alpha E beta 7 integrin in cutaneous T cell lymphoma.
    Simonitsch I, Volc-Platzer B, Mosberger I, Radaszkiewicz T.
    Am J Pathol; 1994 Nov 08; 145(5):1148-58. PubMed ID: 7977645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.